#314 ‒ Rethinking nutrition science: the evolving landscape of obesity treatment, GLP-1 agonists, protein, and the need for higher research standards | David Allison, Ph.D.
David Allison, Dean and Provost Professor at Indiana University Bloomington School of Public Health, discusses the complexities of nutrition science and obesity. He critiques historical public health failures, explores the societal impact of GLP-1 agonists, and highlights significant research gaps in protein intake recommendations.
Deep Dive Analysis
11 Topic Outline
Relationship between Nutrition, Obesity, and Body Composition
Complexity of Nutrition Research and Lack of Progress
Historical Failures of Public Health Efforts in Obesity
The Role of Funding and Scientific Rigor in Obesity Research
Emergence of GLP-1 Agonists for Obesity Treatment
Societal and Ethical Considerations of GLP-1 Agonists
GLP-1 Agonists in Professional Sports and Anti-Doping
Understanding Protein Intake: What is Known and Unknown
Re-evaluating Protein Minimums and Maximums
High Protein Diets and Longevity: Evidence and Speculation
Obesity and Energetics Offerings Newsletter
8 Key Concepts
Energy Balance Model
This model is described as a constraint or restatement of the first law of thermodynamics, meaning changes in energy storage equal changes in energy intake minus changes in energy output. It serves as a fundamental principle that all proposed explanations for weight and mass changes must adhere to.
Nutrient Partitioning
This refers to where the body stores the energy it consumes, such as in fat, muscle, bone, or specific types of fat like visceral or subcutaneous fat. It highlights that food's impact extends beyond total energy to include how that energy is distributed within the body.
Toxic Environment (Obesity Context)
A concept introduced by Kelly Brownell, suggesting that the modern environment, characterized by the pervasive availability of highly palatable, easy-to-acquire, and relatively inexpensive foods, makes it inherently difficult for individuals to avoid obesity. This perspective emphasizes environmental triggers over solely individual behavioral choices.
Compensation (Physiological/Behavioral)
This describes the body's or an individual's tendency to adjust subsequent energy intake or expenditure in response to a previous action. For example, reducing food intake in one context might lead to increased eating later, thereby undermining the effectiveness of dietary interventions.
Safety vs. Risk (Drug Context)
Risk is presented as a factual determination of probabilities, while safety is a social judgment that incorporates values and acceptable levels of risk. This distinction is crucial when evaluating new drugs, as it acknowledges that 'safe' is not an absolute but a culturally and individually determined assessment.
Reproducibility (Research)
This refers to the ability to take a study's original data, run the exact same analysis as described, and obtain the identical result. It is a critical component of scientific rigor, and a lack of reproducibility indicates potential issues in research methodology or reporting.
Verification Problem (Research)
This occurs when a study's results can be reproduced (meaning the original analysis can be replicated), but further scrutiny reveals that the initial analysis was flawed or incorrect, leading to a different, more accurate conclusion. It underscores that reproducibility alone does not guarantee the correctness of a study's findings.
Antagonistic Pleiotropy (Longevity)
This concept suggests that a trait or intervention beneficial for an organism early in life (e.g., for growth or reproduction) might be detrimental later in life, and vice versa. It implies that optimal dietary or lifestyle choices for longevity might change at different stages of life.
11 Questions Answered
Food intake influences energy balance, which is a thermodynamic constraint on weight and mass changes, but many other aspects of food (taste, timing, nutrients) also affect energy expenditure, subsequent intake, and where energy is stored in the body (nutrient partitioning).
While some practical progress has been made (e.g., food safety, micronutrient deficiencies), the field lacks "sea change" or "orbit jumps" in utilitarian knowledge that translates to widespread improvements in obesity outcomes, partly due to the complexity of human biology and environmental factors.
Public health efforts to affect obesity in a meaningful way have thus far been "singularly unimpressive," with recent systematic reviews finding no compelling evidence of consistent, reliable, long-term, clinically or public health meaningful effects on preventing obesity in children or adolescents.
Many interventions are based on superficial assumptions that don't account for physiological compensation (e.g., eating less in one context leading to eating more later) or lack a deep understanding of movement science and energetics, leading to poorly conceived or unimpactful research.
Surveys show that people trust nutrition experts and clinicians more than nutrition scientists, and nutrition science less than other forms of science, partly due to inconsistent findings, poor quality research, and issues with reproducibility and verification.
Unlike previous drugs that were either powerfully effective but unsafe, or reasonably safe but only modestly effective, GLP-1 agonists are both powerfully effective for weight loss and appear to be reasonably safe, marking a significant advancement in obesity treatment.
If issues of safety, cost, and availability are resolved, and individuals are fully informed of known risks and uncertainties, then a libertarian view would suggest it's their choice, as personal quality of life and non-medical desires can be as valid as medical motivations for other conditions like depression.
This is a complex question that depends on the underlying principles of anti-doping agencies and the specific sport's rules, as weight management is crucial in many sports, and the drugs could be seen as enhancing performance by making weight loss easier, similar to other banned substances.
Many experts believe the traditional RDA of 0.8 grams per kilogram body weight is too low for thriving, suggesting that while it allows for survival, it may not be optimal for health, longevity, or performance.
Despite common presumptions and warnings about excessive protein intake leading to kidney damage, bone loss, or "rabbit starvation," there is a lack of compelling trial data in normal adults to definitively demonstrate these negative health problems as a direct result of high protein consumption.
There is very low compelling evidence to suggest that high-protein diets reduce human longevity; in fact, there may be reasons to believe the contrary, and findings from other species (like butterflies or mice) may not directly translate to humans.
14 Actionable Insights
1. Understand Energy Balance
Recognize that changes in body energy stores are fundamentally governed by the balance between energy intake (food) and energy output (expenditure). This is a foundational constraint for understanding weight and body composition.
2. Prioritize Caloric Intake
Focus on the total number of calories consumed as the primary driver of weight changes, acknowledging that other food aspects can influence how many calories you ultimately eat.
3. Re-evaluate Protein RDA
Consider that the traditional Recommended Dietary Allowance (RDA) for protein (0.8 grams per kilogram of body weight) may be too low for optimal health and ’thriving,’ suggesting a potentially higher intake could be beneficial.
4. Question High Protein Risks
Be skeptical of claims that high protein intake (e.g., above 3 grams per kilogram) in healthy individuals leads to kidney damage, bone loss, or ‘rabbit starvation,’ as robust trial data supporting these assertions are largely lacking.
5. Challenge Protein Anabolic Thresholds
Do not rigidly adhere to specific protein thresholds (e.g., 20-30 grams per meal) as the minimum required for anabolic effects, as the precise nature and certainty of such biological ‘step functions’ are not definitively established by current research.
6. Don’t Assume Carbs Boost Anabolism
Avoid the assumption that consuming carbohydrates alongside protein is necessary to enhance muscle anabolism, as compelling evidence for this specific effect is not currently available.
7. Assess Longevity vs. Quality of Life
Consider your personal values and trade-offs when making health decisions, as optimizing for longevity is only one factor; prioritizing strength, energy, or aesthetics may lead to different choices.
8. Challenge GLP-1 Motivation Judgments
Dismiss moralistic judgments about the motivation for using GLP-1 agonists for weight loss (e.g., for cosmetic reasons versus health), as there is no evidence that health-motivated individuals achieve better outcomes than those with other motivations.
9. Understand GLP-1 Long-Term Unknowns
Be aware that the long-term safety and effects of GLP-1 agonists (e.g., beyond a few years) are not fully known, especially regarding usage for 40 years or in populations not thoroughly studied in clinical trials.
10. Monitor GLP-1 Heart Rate Effects
If considering GLP-1 agonists, particularly for non-critical weight loss, be mindful of potential side effects such as an increase in resting heart rate (around 10 beats per minute) and a slight decrease in heart rate variability, and weigh these against personal benefits.
11. Demand Compounding Pharmacy Data
When considering GLP-1 agonists from compounding pharmacies, demand clear evidence and data on their quality control procedures to ensure product safety and efficacy, rather than dismissing all such pharmacies or accepting them uncritically.
12. Subscribe to Obesity & Energetics
Subscribe to the free ‘Obesity and Energetics Offerings’ newsletter to stay updated on scientific papers and media articles related to obesity, energy, and nutrition.
13. Develop Media Literacy
Regularly review the ‘headline versus study’ section of the ‘Obesity and Energetics Offerings’ newsletter to cultivate critical thinking skills and avoid being misled by sensationalized or inaccurate media headlines about scientific research.
14. Adapt Diet to Life Stage
Recognize that optimal dietary strategies, including protein intake, may need to be adjusted throughout different periods of life, as what is beneficial early in life may not be optimal later on.
8 Key Quotes
Matter and energy can neither be created nor destroyed, but only converted. It is a constraint by which all other descriptions of what happens with weight and mass and food intake and energy intake and energy expenditure must operate.
David Allison
We don't have the sort of sea change, the real orbit jumps in knowledge of a utilitarian, useful knowledge, knowledge that helps us change the way we do things now that lead to better outcomes. That we don't yet have.
David Allison
I think that's where we're going to go with obesity. And he said, but we're just sort of getting to the breaking point. I think that's what we're seeing now with the GLP-1 agonists, as well as some other drugs.
David Allison
We now have ones that are powerfully effective and appear safe, reasonably safe. Safety is a social judgment, not a factual determination. Risk is a factual determination. Safety is a social judgment.
David Allison
The third part is a moral judgment, not a factual judgment. The first and the second are true. And what they really tell you is, therefore, the cost benefit analysis has to be viewed through the lens of that patient population.
Peter Attia
If I try out and I don't do well for the basketball team because I'm short, I don't call that bias because intrinsic to the idea of basketball is, these are the rules. We don't have springboards for shorter guys.
David Allison
Yes, we can think about treating diseases, we can think about preventing diseases, but neither of those are equivalent to optimizing our lives and our health.
David Allison
If anybody else knows them, please send them to me.
David Allison